Found: 17
Select item for more details and to access through your institution.
Osteoblast Lineage Cells Play an Essential Role in Periodontal Bone Loss Through Activation of Nuclear Factor-Kappa B.
- Published in:
- Scientific Reports, 2015, p. 16694, doi. 10.1038/srep16694
- By:
- Publication type:
- Article
NF-κB Has a Direct Role in Inhibiting Bmp-and Wnt-Induced Matrix Protein Expression.
- Published in:
- Journal of Bone & Mineral Research, 2016, v. 31, n. 1, p. 52, doi. 10.1002/jbmr.2592
- By:
- Publication type:
- Article
Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer.
- Published in:
- FASEB Journal, 2011, v. 25, n. 4, p. 1198, doi. 10.1096/fj.10-167924
- By:
- Publication type:
- Article
Lupeol inhibits proliferation of human prostate cancer cells by targeting {beta}-catenin signaling.
- Published in:
- Carcinogenesis, 2009, v. 30, n. 5, p. 808, doi. 10.1093/carcin/bgp044
- By:
- Publication type:
- Article
Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201.
- Published in:
- Journal of Neuro-Oncology, 2019, v. 145, n. 1, p. 97, doi. 10.1007/s11060-019-03271-3
- By:
- Publication type:
- Article
The dietary terpene lupeol targets colorectal cancer cells with constitutively active Wnt/β-catenin signaling.
- Published in:
- Molecular Nutrition & Food Research, 2013, v. 57, n. 11, p. 1950, doi. 10.1002/mnfr.201300155
- By:
- Publication type:
- Article
BMI1 Polycomb Group Protein Acts as a Master Switch for Growth and Death of Tumor Cells: Regulates TCF4-Transcriptional Factor-Induced BCL2 Signaling
- Published in:
- PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0060664
- By:
- Publication type:
- Article
Modulation of Wnt/β-catenin signaling pathway by bioactive food components.
- Published in:
- Carcinogenesis, 2012, v. 33, n. 3, p. 483, doi. 10.1093/carcin/bgr305
- By:
- Publication type:
- Article
Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapy.
- Published in:
- Neuro-Oncology Advances, 2022, v. 4, n. 1, p. 1, doi. 10.1093/noajnl/vdac143
- By:
- Publication type:
- Article
Correction: Hu, W., et al. Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. Cancers 2020, 12 , 2436.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2436, doi. 10.3390/cancers12092436
- By:
- Publication type:
- Article
Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant glioma.
- Published in:
- Neuro-Oncology, 2024, v. 26, p. S155, doi. 10.1093/neuonc/noae001
- By:
- Publication type:
- Article
ACTION: a randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3 K27M-mutant diffuse glioma.
- Published in:
- Neuro-Oncology, 2024, v. 26, p. S173, doi. 10.1093/neuonc/noae031
- By:
- Publication type:
- Article
Selective DRD2 antagonist and ClpP agonist ONC201 in a recurrent non-midline H3 K27M-mutant glioma cohort.
- Published in:
- Neuro-Oncology, 2024, v. 26, p. S165, doi. 10.1093/neuonc/noae021
- By:
- Publication type:
- Article
Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 8, p. 1366, doi. 10.1093/neuonc/noac030
- By:
- Publication type:
- Article
Biological activity of weekly ONC201 in adult recurrent glioblastoma patients.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 1, p. 94, doi. 10.1093/neuonc/noz164
- By:
- Publication type:
- Article
PDCT-06. PHASE 1 STUDY OF ONC201 IN PEDIATRIC PATIENTS WITH H3 K27M-MUTANT HIGH GRADE GLIOMA OR NEWLY DIAGNOSED DIPG.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi201, doi. 10.1093/neuonc/noy148.836
- By:
- Publication type:
- Article